These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 26506947)
21. Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus. Schadlow MB; Anhalt GJ; Sinha AA J Drugs Dermatol; 2003 Oct; 2(5):564-7. PubMed ID: 14558407 [TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. Martínez De Pablo MI; Iranzo P; Mascaró JM; Llambrich A; Baradad M; Herrero C Acta Derm Venereol; 2005; 85(3):233-5. PubMed ID: 16040408 [TBL] [Abstract][Full Text] [Related]
23. Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities. Rossum MM; Verhaegen NT; Jonkman MF; Mackenzie MA; Koster A; Van Der Valk PG; Span LF Leuk Lymphoma; 2004 Nov; 45(11):2327-32. PubMed ID: 15512825 [TBL] [Abstract][Full Text] [Related]
30. Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy. Hoque SR; Black MM; Cliff S Clin Exp Dermatol; 2007 Mar; 32(2):172-5. PubMed ID: 17342796 [TBL] [Abstract][Full Text] [Related]
32. Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus. Kikuchi T; Mori T; Shimizu T; Koda Y; Abe R; Kurihara Y; Funakoshi T; Yamagami J; Sato H; Tsunoda K; Amagai M; Okamoto S Ann Hematol; 2017 Jul; 96(7):1221-1222. PubMed ID: 28447163 [No Abstract] [Full Text] [Related]
33. Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine. Kuriyama K; Kitamura Y; Tsuji T; Nishikawa R; Nagata H; Ohshiro M; Sugitani M; Hirakawa Y; Matsumoto Y; Iwai T; Uchiyama H Curr Probl Cancer; 2022 Apr; 46(2):100813. PubMed ID: 34844771 [TBL] [Abstract][Full Text] [Related]
34. Rituximab and intravenous immunoglobulin as alternatives to long-term systemic corticosteroids in the treatment of pemphigus: a single center case series of 63 patients. Brown AE; Motaparthi K; Hsu S Dermatol Online J; 2018 Jan; 23(12):. PubMed ID: 29447653 [TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and appearance of anti-BP180 antibodies in the late stage of the disease. Kanaoka M; Matsukura S; Ishikawa H; Matsuura M; Ishii N; Hashimoto T; Aihara M J Dermatol; 2014 Jul; 41(7):628-30. PubMed ID: 24985544 [TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic pemphigus with Castleman's disease and bronchiolitis obliterans. Jindal T; Meena M; Kumar A; Khaitan BK Pediatr Int; 2011 Dec; 53(6):1108-9. PubMed ID: 22181577 [No Abstract] [Full Text] [Related]
37. Clinical Analysis of Unicentric Castleman's Disease with Paraneoplastic Pemphigus and Bronchiolitis Obliterans. Zhen JF; Zhang L; Cao XX; Feng J; Zhou DB; Lin SB; Li J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):492-498. PubMed ID: 28877826 [TBL] [Abstract][Full Text] [Related]
38. Anti-desmoglein antibody-negative paraneoplastic pemphigus successfully treated with rituximab. Kanwar AJ; Vinay K; Varma S; Koga H; Ishii N; Hashimoto T Int J Dermatol; 2015; 54(5):576-9. PubMed ID: 24738571 [No Abstract] [Full Text] [Related]
39. Paraneoplastic Pemphigus: A Striking Complication of Undiagnosed Lymphoma. Adnani BO; O' Brien K; Myint ZW; Adler BL Case Rep Hematol; 2022; 2022():3641474. PubMed ID: 36330223 [TBL] [Abstract][Full Text] [Related]
40. Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature. Lane JE; Woody C; Davis LS; Guill MF; Jerath RS Pediatrics; 2004 Oct; 114(4):e513-6. PubMed ID: 15466078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]